Andy Jones

Articles

Pharma is moving towards greater patientcentricity – but there are plenty of obstacles and commercial pressures remaining, reports Andrew McConaghie.

News

Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.